Date Filed | Type | Description |
10/06/2023 |
4
| BERSANI PIETRO (CEO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 65,600 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Misajon Pamela (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
10/06/2023 |
4
| NAGEL MICHAEL (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 18,000 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Catlin Michael (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Hungerford Brian (CFO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 21,900 restricted stock units
@ $0 |
|
10/03/2023 |
3
| Hungerford Brian (CFO) has filed a Form 3 on Kiromic Biopharma, Inc. |
10/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/02/2023 |
8-K
| Quarterly results |
09/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/10/2023 |
3
| Catlin Michael (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
08/02/2023 |
3
| Misajon Pamela (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
07/27/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
07/25/2023 |
8-K
| Quarterly results |
07/24/2023 |
8-K
| Quarterly results |
07/19/2023 |
8-K
| Quarterly results |
07/18/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
07/18/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
06/29/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
06/16/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
06/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/19/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/15/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/12/2023 |
8-K
| Other Events Interactive Data |
04/28/2023 |
8-K
| Quarterly results |
04/28/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/17/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
03/10/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
|